Advertisement

Journal of Racial and Ethnic Health Disparities

, Volume 6, Issue 6, pp 1157–1166 | Cite as

Assessing the Acceptability of a Mindfulness-Based Cognitive Therapy Intervention for African-American Women Living with HIV/AIDS

  • Josalin J. Hunter-JonesEmail author
  • Shantesica M. Gilliam
  • April L. Carswell
  • Nathan B. Hansen
Article

Abstract

African-American HIV-seropositive women are at elevated risk for depressive symptoms compared to their seropositive counterparts. Depressive symptoms have been linked to HIV/AIDS-related health predictors and outcomes such as medication and care adherence, and viral load. Project UPLIFT, a mindfulness-based cognitive therapy intervention originally designed for persons with epilepsy has been shown effective to reduce depressive and anxiety symptoms. Focus groups were conducted to assess the appropriateness and acceptability of UPLIFT for African-American HIV-seropositive women and to obtain feedback on needed modifications. The focus groups, including cisgender and transgender African-American HIV-seropositive women, revealed, while well received, modifications should include lowering the reading level of content and altering specific mindfulness-based exercises to make them relevant and acceptable to the target population. This qualitative work demonstrates UPLIFT could be a promising avenue to improve the mental health of African-American HIV-seropositive women, a group for which mindfulness interventions had not been previously considered.

Significance

Mindfulness-based interventions have been found effective in reducing depression, anxiety, and chronic pain. Further, it has been used for groups living with chronic illness, particularly HIV/AIDS. It has helped to improve mental and behavioral health, as well as increase CD4 count and reduce viral load for some samples of people living with HIV/AIDS. African-American women living with HIV/AIDS are especially vulnerable to poor mental and behavioral health given their experience of mental illness and hesitancy to engage mental healthcare. Though used for other groups of people living with HIV/AIDS, mindfulness-based cognitive therapy has not previously been considered for this population. This study explored the acceptability and feasibility of an MBCT intervention for this group. The data suggests that this intervention could be potentially useful in improving the mental health of this population, and includes suggestions for making the intervention culturally relevant.

Keywords

HIV/AIDS Mindfulness Mindfulness-based cognitive therapy Depression Anxiety Telehealth Telephone 

Notes

References

  1. 1.
    National Institute of Mental Health (U.S.). Depression and HIV/AIDS. NIH publication no. 02-5005.Google Scholar
  2. 2.
    Chaudoir SR, Norton WE, Earnshaw VA, Moneyham L, Mugavero MJ, Hiers KM. Coping with HIV stigma: do proactive coping and spiritual peace buffer the effect of stigma on depression? AIDS Behav. 2012;16(8):2382–91.  https://doi.org/10.1007/s10461-011-0039-3.CrossRefPubMedGoogle Scholar
  3. 3.
    Persons E, Kershaw T, Sikkema KJ, Hansen NB. The impact of shame on health-related quality of life among HIV-positive adults with a history of childhood sexual abuse. AIDS Patient Care STDs. 2010;24(9):571–80.  https://doi.org/10.1089/apc.2009.0209.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Simoni JM, Ng MT. Trauma, coping, and depression among women with HIV/AIDS in New York City. AIDS Care. 2000;12(5):567–80.  https://doi.org/10.1080/095401200750003752.CrossRefPubMedGoogle Scholar
  5. 5.
    Kalichman SC, Heckman T, Kochman A, Sikkema K, Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv. 2000;51(7):903–7.CrossRefGoogle Scholar
  6. 6.
    Vyavaharkar M, Moneyham L, Tavakoli A, Phillips KD, Murdaugh C, Jackson K, et al. Social support, coping, and medication adherence among HIV-positive women with depression living in rural areas of the southeastern United States. AIDS Patient Care STDs. 2007;21(9):667–80.  https://doi.org/10.1089/apc.2006.0131.CrossRefPubMedGoogle Scholar
  7. 7.
    Bennett DS, Traub K, Mace L, Juarascio A, O'Hayer CV. Shame among people living with HIV: a literature review. AIDS Care. 2015;28:1–5.  https://doi.org/10.1080/09540121.2015.1066749.CrossRefGoogle Scholar
  8. 8.
    Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS Behav. 2013;17(5):1785–95.  https://doi.org/10.1007/s10461-013-0437-9.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    HIV Among Women. Centers for Disease Control and Prevention. Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients. 2017.Google Scholar
  10. 10.
    Moneyham L, Sowell R, Seals B, Demi A. Depressive symptoms among African American women with HIV disease. Sch Inq Nurs Pract. 2000;14(1):9–39 discussion 41-6.PubMedGoogle Scholar
  11. 11.
    Miles MS, Holditch-Davis D, Pedersen C, Eron JJ Jr, Schwartz T. Emotional distress in African American women with HIV. J Prev Interv Community. 2007;33(1–2):35–50.  https://doi.org/10.1300/J005v33n01_04.CrossRefPubMedGoogle Scholar
  12. 12.
    Cook JA, Burke-Miller JK, Grey DD, Cocohoba J, Liu C, Schwartz RM, et al. Do HIV-positive women receive depression treatment that meets best practice guidelines? AIDS Behav. 2014;18(6):1094–102.  https://doi.org/10.1007/s10461-013-0679-6.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cook J, Grey D, Burke-Miller J, Cohen M, Anastos K, Gandhi M, et al. Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care. 2006;18(2):93–100.CrossRefGoogle Scholar
  14. 14.
    Tsao JC, Dobalian A, Moreau C, Dobalian K. Stability of anxiety and depression in a national sample of adults with human immunodeficiency virus. J Nerv Ment Dis. 2004;192(2):111–8.CrossRefGoogle Scholar
  15. 15.
    Valente SM. Depression and HIV disease. J Assoc Nurses AIDS Care. 2003;14(2):41–51.CrossRefGoogle Scholar
  16. 16.
    Willie TC, Overstreet NM, Sullivan TP, Sikkema KJ, Hansen NB. Barriers to HIV medication adherence: examining distinct anxiety and depression symptoms among women living with HIV who experienced childhood sexual abuse. Behav Med. 2016;42(2):120–7.CrossRefGoogle Scholar
  17. 17.
    Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. JAIDS. 2002;30(4):401–9.PubMedGoogle Scholar
  18. 18.
    Wingood GM, DiClemente RJ, Mikhail I, Lang DL, McCree DH, Davies SL, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S58–67.CrossRefGoogle Scholar
  19. 19.
    Fuller TR, Brown M, King W, Prather C, Cazaubon J, Mack J, et al. The SISTA pilot project: understanding the training and technical assistance needs of community-based organizations implementing HIV prevention interventions for African American women--implications for a capacity building strategy. Women Health. 2007;46(2–3):167–86.  https://doi.org/10.1300/J013v46n02_11.CrossRefPubMedGoogle Scholar
  20. 20.
    Thompson NJ, Patel AH, Selwa LM, Stoll SC, Begley CE, Johnson EK, et al. Expanding the efficacy of project UPLIFT: distance delivery of mindfulness-based depression prevention to people with epilepsy. J Consult Clin Psychol. 2015;83(2):304–13.  https://doi.org/10.1037/a0038404.CrossRefPubMedGoogle Scholar
  21. 21.
    Thompson NJ, Walker ER, Obolensky N, Winning A, Barmon C, Diiorio C, et al. Distance delivery of mindfulness-based cognitive therapy for depression: project UPLIFT. Epilepsy Behav. 2010;19(3):247–54.  https://doi.org/10.1016/j.yebeh.2010.07.031.CrossRefPubMedGoogle Scholar
  22. 22.
    Walker ER, Obolensky N, Dini S, Thompson NJ. Formative and process evaluations of a cognitive-behavioral therapy and mindfulness intervention for people with epilepsy and depression. Epilepsy Behav. 2010;19(3):239–46.  https://doi.org/10.1016/j.yebeh.2010.07.032.CrossRefPubMedGoogle Scholar
  23. 23.
    Carlson LE. Mindfulness-based interventions for physical conditions: a narrative review evaluating levels of evidence. ISRN Psychiatry. 2012;2012:651583.  https://doi.org/10.5402/2012/651583. CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Creswell JD, Myers HF, Cole SW, Irwin MR. Mindfulness meditation training effects on CD4+ T lymphocytes in HIV-1 infected adults: a small randomized controlled trial. Brain Behav Immun. 2009;23(2):184–8.  https://doi.org/10.1016/j.bbi.2008.07.004.CrossRefPubMedGoogle Scholar
  25. 25.
    Gonzalez-Garcia M, Ferrer MJ, Borras X, Munoz-Moreno JA, Miranda C, Puig J, et al. Effectiveness of mindfulness-based cognitive therapy on the quality of life, emotional status, and CD4 cell count of patients aging with HIV infection. AIDS Behav. 2013;18:676–85.  https://doi.org/10.1007/s10461-013-0612-z.CrossRefPubMedGoogle Scholar
  26. 26.
    Jam S, Imani AH, Foroughi M, SeyedAlinaghi S, Koochak HE, Mohraz M. The effects of mindfulness-based stress reduction (MBSR) program in Iranian HIV/AIDS patients: a pilot study. Acta Med Iran. 2010;48(2):101–6.PubMedGoogle Scholar
  27. 27.
    Moskowitz JT, Duncan LG, Moran PJ, Acree M, Epel ES, Kemeny ME, et al. Dispositional mindfulness in people with HIV: associations with psychological and physical health. Pers Individ Differ. 2015;86:88–93.  https://doi.org/10.1016/j.paid.2015.05.039.CrossRefGoogle Scholar
  28. 28.
    Riley KE, Kalichman S. Mindfulness-based stress reduction for people living with HIV/AIDS: preliminary review of intervention trial methodologies and findings. Health Psychol Rev. 2015;9(2):224–43.  https://doi.org/10.1080/17437199.2014.895928.CrossRefPubMedGoogle Scholar
  29. 29.
    Robinson FP, Mathews HL, Witek-Janusek L. Psycho-endocrine-immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasiexperimental study. J Altern Complement Med. 2003;9(5):683–94.  https://doi.org/10.1089/107555303322524535.CrossRefPubMedGoogle Scholar
  30. 30.
    SeyedAlinaghi S, Jam S, Foroughi M, Imani A, Mohraz M, Djavid GE, et al. Randomized controlled trial of mindfulness-based stress reduction delivered to human immunodeficiency virus-positive patients in Iran: effects on CD4+ T lymphocyte count and medical and psychological symptoms. Psychosom Med. 2012;74(6):620–7.  https://doi.org/10.1097/PSY.0b013e31825abfaa.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Yang Y, Liu Y-H, Zhang H-F, Liu J-Y. Effectiveness of mindfulness-based stress reduction and mindfulness-based cognitive therapies on people living with HIV: a systematic review and meta-analysis. Int J Nurs Sci. 2015;2(3):283–94.  https://doi.org/10.1016/j.ijnss.2015.07.003.CrossRefGoogle Scholar
  32. 32.
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefGoogle Scholar
  33. 33.
    Fullilove MT. Psychiatric implications of displacement: contributions from the psychology of place. Am J Psychiatry. 1996;153(12):1516–23.CrossRefGoogle Scholar
  34. 34.
    Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: psychometric properties and association with breast cancer screening. Prev Med. 2004;38(2):209–18.  https://doi.org/10.1016/j.ypmed.2003.09.041.CrossRefPubMedGoogle Scholar
  35. 35.
    Newkirk LA, Kim JM, Thompson JM, Tinklenberg JR, Yesavage JA, Taylor JL. Validation of a 26-point telephone version of the mini-mental state examination. J Geriatr Psychiatry Neurol. 2004;17(2):81–7.  https://doi.org/10.1177/0891988704264534.CrossRefPubMedGoogle Scholar
  36. 36.
    Eaton DK, Kann L, Kinchen S, Shanklin S, Flint KH, Hawkins J, et al. Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ. 2012;61(4):1–162.PubMedGoogle Scholar
  37. 37.
    Dalmida SG, Holstad MM, Diiorio C, Laderman G. Spiritual well-being and health-related quality of life among African-American women with HIV/AIDS. Appl Res Qual Life. 2011;6(2):139–57.  https://doi.org/10.1007/s11482-010-9122-6.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Dalmida SG, Holstad MM, DiIorio C, Laderman G. The meaning and use of spirituality among African American women living with HIV/AIDS. West J Nurs Res. 2012;34(6):736–65.  https://doi.org/10.1177/0193945912443740.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Braxton ND, Lang DL, J MS, Wingood GM, DiClemente RJ. The role of spirituality in sustaining the psychological well-being of HIV-positive black women. Women Health. 2007;46(2–3):113–29.  https://doi.org/10.1300/J013v46n02_08.CrossRefPubMedGoogle Scholar
  40. 40.
    Amutio A, Franco C, Pérez-Fuentes MC, Gázquez JJ, Mercader I. Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients. Front Psychol. 2015;5:1572.CrossRefGoogle Scholar
  41. 41.
    Dalmida SG. Spirituality, mental health, physical health, and health-related quality of life among women with HIV/AIDS: integrating spirituality into mental health care. Issues Ment Health Nurs. 2006;27(2):185–98.  https://doi.org/10.1080/01612840500436958.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Dalmida SG, Holstad MM, Diiorio C, Laderman G. Spiritual well-being, depressive symptoms, and immune status among women living with HIV/AIDS. Women Health. 2009;49(2–3):119–43.  https://doi.org/10.1080/03630240902915036.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© W. Montague Cobb-NMA Health Institute 2019

Authors and Affiliations

  1. 1.SSchool of Social Work, College of Health and Human SciencesUniversity of North Carolina WilmingtonWilmingtonUSA
  2. 2.Department of Health Promotion and Behavior, College of Public HealthUniversity of GeorgiaAthensUSA
  3. 3.ICFAtlantaUSA

Personalised recommendations